Description

Introducing Glimvay-2: Advanced Diabetes Care for Optimal Glucose Control

Dual-Action Glucose Management: Glimvay-2 integrates Glimepiride (2mg) and Metformin (500mg) in a bilayer tablet. Glimepiride enhances insulin secretion, while Metformin improves insulin sensitivity, ensuring effective blood glucose management.

Extended Release Technology: Glimvay-2’s bilayer formulation provides sustained release of Metformin, maintaining stable glucose levels throughout the day and optimizing diabetic control.

Convenient Once-Daily Dosing: Simplifying treatment, Glimvay-2 requires just one daily dose, promoting adherence and enhancing patient convenience.

Proven Clinical Efficacy: Backed by rigorous clinical trials, Glimvay-2 effectively manages blood sugar levels, providing confidence to healthcare providers and patients alike.

Commitment to Pharmaceutical Excellence: Manufactured by Anevay Pharmaceuticals, Glimvay-2 upholds stringent quality standards. Each batch undergoes meticulous testing to ensure safety, efficacy, and reliability in diabetes care. Our commitment to pharmaceutical integrity ensures that every tablet meets global healthcare standards, fostering trust and peace of mind for patients managing diabetes.